Patents by Inventor Ozgur Akcan

Ozgur Akcan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911510
    Abstract: The invention relates to a solid oral extended release pharmaceutical dosage form comprising an extended release matrix formulation. The extended release matrix formulation comprises (1) at least one active agent, (2) at least one anionic surfactant, and (3) at least about 40% by weight (based on the weight of the extended release matrix formulation) of at least one polyethylene oxide. In certain embodiments, the molar ratio of the at least one anionic surfactant to the at least one active agent is from about 1:2 to about 10:1.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: February 27, 2024
    Assignee: Purdue Pharma L.P
    Inventors: Ozgur Akcan, Richard Mannion
  • Publication number: 20210205295
    Abstract: The invention relates to a solid dosage form comprising a core-shell structure comprising two or more different active agents, wherein the core-shell structure comprises (1) a core comprising a first matrix formulation, the first matrix formulation comprising at least one active agent selected from the group of an active agent (A) and an active agent (B); and (2) a shell encasing the core and comprising a second matrix formulation, wherein the weight ratio of the first matrix formulation to the second matrix formulation is from about 1:10 to about 4:1. In certain embodiments, the solid dosage forms of the invention are in oral solid extended release dosage forms, which provide an extended release of at least a portion of at least one active agent included therein.
    Type: Application
    Filed: October 19, 2018
    Publication date: July 8, 2021
    Inventors: Ozgur Akcan, Stephen Harris, Richard Mannion
  • Publication number: 20210077409
    Abstract: The invention relates to a solid oral extended release pharmaceutical dosage form comprising an extended release matrix formulation. The extended release matrix formulation comprises (1) at least one active agent, (2) at least one anionic surfactant, and (3) at least about 40% by weight (based on the weight of the extended release matrix formulation) of at least one polyethylene oxide. In certain embodiments, the molar ratio of the at least one anionic surfactant to the at least one active agent is from about 1:2 to about 10:1.
    Type: Application
    Filed: August 30, 2018
    Publication date: March 18, 2021
    Inventors: Ozgur Akcan, Richard Mannion
  • Publication number: 20070111914
    Abstract: A method of washing laundry, the method comprising washing laundry in an aqueous medium with two separate compositions: a laundry detergent composition comprising from about 1% to about 80% of an alkoxylated ester surfactant and a rinse aid composition comprising from about 0.001% to about 100% of a carboxylic ester hydrolase enzyme, to result in the substantial reduction of foaming. Laundry kits based on the two compositions are also described.
    Type: Application
    Filed: November 16, 2005
    Publication date: May 17, 2007
    Inventors: Feng-Lung Hsu, Ozgur Akcan, Sudhakar Puvvada, Myongsuk Bae-Lee